News
The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting ...
The investigation demonstrated that dual targeting of DOT1L and EZH2 effectively prevented human GCB-DLBCL xenograft growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback